Marga Bouma

Differentiation-Defective Human Induced Pluripotent Stem Cells Reveal Strengths and Limitations of the Teratoma Assay and In Vitro Pluripotency Assays

Marga Bouma, Maarten van Iterson, Bart Janssen et al. · Stem Cell Reports · 2017 · 43 citations · Full text

Life Sciences, Cell Biology, Developmental Biology +12

High-impact <i>FN1</i> mutation decreases chondrogenic potential and affects cartilage deposition via decreased binding to collagen type II

Marcella van Hoolwerff, Alejandro Rodríguez Ruiz, Marga Bouma et al. · Science Advances · 2021 · 43 citations · Full text

Medicine, Cell Biology, Molecular Biology +13

Zebrafish embryotoxicity test for developmental (neuro)toxicity: Demo case of an integrated screening approach system using anti-epileptic drugs

Anna Beker van Woudenberg, Cor Snel, Eke Rijkmans et al. · Reproductive Toxicology · 2014 · 42 citations

Pharmacy, Developmental Biology, Toxicology +17

Generation of 3 spinocerebellar ataxia type 1 (SCA1) patient-derived induced pluripotent stem cell lines LUMCi002-A, B, and C and 2 unaffected sibling control induced pluripotent stem cell lines LUMCi003-A and B

Ronald A.M. Buijsen, Sarah L. Gardiner, Marga Bouma et al. · Stem Cell Research · 2018 · 32 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17